Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Mesoblast Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

02 May 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - MESOBLAST LTD (MSB-AU)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

01 May 2015 Thomson Reuters Stock Report 11 $25.00

Mesoblast Limited - Appendix 3C - Announcement of Buy-Back (Except Minimum Holding Buy-Back)

01 May 2015 irasia.com 4 $46.00

ValuEngine Industry Report for Medical-biomed/genetics(MBLTY)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

27 Apr 2015 ValuEngine, Inc. 10 $49.00

Mesoblast limited: Downgraded to Risky

23 Apr 2015 Sadif Analytics Prime 3 $10.00

Mesoblast Limited - Appendix 4C - Quarterly Report for Entities Admitted on the Basis of Commitments

17 Apr 2015 irasia.com 5 $58.00

Mesoblast Limited - Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement

17 Apr 2015 irasia.com 10 $115.00

Mesoblast Limited - Celgene and Mesoblast Enter into Equity Placement and Right of First Refusal Agreement to Certain Disease Fields

13 Apr 2015 irasia.com 1 $12.00

Mesoblast Limited - Mesoblast Phase 3 Program for Degenerative Disc Disease to Include European Sites after Positive Meeting with European Medicines Agency

08 Apr 2015 irasia.com 1 $12.00

ValuEngine Rating and Forecast Report for MBLTY

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

06 Apr 2015 ValuEngine, Inc. 10 $25.00